Penumbra (PEN)
(Delayed Data from NYSE)
$175.99 USD
-1.10 (-0.62%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $175.90 -0.09 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Bottom 34% (164 out of 249)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.53 | 1.57 | 9.99 |
Current Quarter Estimate | 0.56 | 3.93 | 61.00 |
Year Ago Quarter Estimate | 0.43 | 3.85 | 54.84 |
Next Quarter Estimate | 0.89 | 3.92 | 63.00 |
Next Year Estimate | 3.91 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 37.32 | 12.00 | 15.67 |
Next Year | 36.24 | 21.70 | 9.31 |
Last 5 Years | 32.80 | 10.20 | 8.10 |
Next 5 Years | 34.40 | 14.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 78.01 | 29.13 |
Price/Book (MRQ) | 5.70 | 2.37 |
Price/Cash Flow (MRFY) | 62.63 | 17.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 8.52% | 7.19% |
Return on Equity (TTM) | 7.83% | -233.34% |
Debt to Equity (MRQ) | NA | 30.84 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.